Key facts
- Notable investors include Shenzhen Capital Group, Guoli Minsheng, Moutai (Guizhou) Private Equity Fund Management.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Jize Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Jize Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jize Biotechnology
Operator of a biotechnology company intended for pharmaceutical manufacturers and healthcare providers. The company focuses on technological innovation and the industrialization of artificial bear bile powder, thereby enabling clients to leverage technological innovation to eliminate reliance on animal-derived bile products.
- Sector
- Healthcare
- HQ
- Chongqing, China
- Founded
- 2019
- Employees
- 12
- Ownership
- Privately Held (backing)
Jize Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jize Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jize Biotechnology in its N-PORT filings yet. We sweep new filings monthly.